Central mfERG amplitude ratio as a predictor for visual outcome of macular hole surgery (2020)
- Authors:
- USP affiliated authors: JORGE, RODRIGO - FMRP ; MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP ; CARAVELAS, RENATA DO AMARAL MORETO - FMRP
- Unidade: FMRP
- DOI: 10.1007/s10633-019-09716-4
- Subjects: RETINA; MÁCULA LÚTEA; PROCEDIMENTOS CIRÚRGICOS OFTALMOLÓGICOS; ACUIDADE VISUAL
- Keywords: Macular hole; Multifocal electroretinography; ILM peeling; Vitrectomy
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2020
- Source:
- Título: Documenta Ophthalmologica
- ISSN: 0012-4486
- Volume/Número/Paginação/Ano: v. 140, n. 1, p. 23-30, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CARAVELAS, Renata do Amaral Moreto et al. Central mfERG amplitude ratio as a predictor for visual outcome of macular hole surgery. Documenta Ophthalmologica, v. 140, n. 1, p. 23-30, 2020Tradução . . Disponível em: https://doi.org/10.1007/s10633-019-09716-4. Acesso em: 28 fev. 2026. -
APA
Caravelas, R. do A. M., Perches, A. C. B. D. L., Almeida, F., Jorge, R., Messias, A. M. V., & Gekeler, K. (2020). Central mfERG amplitude ratio as a predictor for visual outcome of macular hole surgery. Documenta Ophthalmologica, 140( 1), 23-30. doi:10.1007/s10633-019-09716-4 -
NLM
Caravelas R do AM, Perches ACBDL, Almeida F, Jorge R, Messias AMV, Gekeler K. Central mfERG amplitude ratio as a predictor for visual outcome of macular hole surgery [Internet]. Documenta Ophthalmologica. 2020 ; 140( 1): 23-30.[citado 2026 fev. 28 ] Available from: https://doi.org/10.1007/s10633-019-09716-4 -
Vancouver
Caravelas R do AM, Perches ACBDL, Almeida F, Jorge R, Messias AMV, Gekeler K. Central mfERG amplitude ratio as a predictor for visual outcome of macular hole surgery [Internet]. Documenta Ophthalmologica. 2020 ; 140( 1): 23-30.[citado 2026 fev. 28 ] Available from: https://doi.org/10.1007/s10633-019-09716-4 - Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Retinal safety and efficacy of a dexamethasone biodegradable implant to treat macular edema associated to retinal vein occlusion: a phase I/II clinical trial
- Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Intravitreal autologous bone marrow derived stem cells in dry age-related macular degeneration
- Intravitreal autologous bone marrow derived stem cells in ischemic maculopathy
- Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study
- Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema
- Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema
Informações sobre o DOI: 10.1007/s10633-019-09716-4 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003082069.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
